Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TBE + influenza vaccine
- Development stage
- Preclinical
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Intranasal
01
Overview
A combination vaccine approach that includes both Tick-Borne Encephalitis (TBE) and influenza vaccines. In research settings, this combination has been used to study immune responses, particularly in individuals who are nonresponders to certain vaccines. The TB/FLU-06E variant specifically uses an attenuated influenza vector expressing the mycobacterial antigen ESAT-6, which activates T-cellular immunity.
- Other names
- TB/FLU-06E
02
Targets
TCR (T cell antigen receptor complex)T-cell receptor recognizing influenza virus-derived peptide–MHC-II complexes
Beyond the preview
Go deeper on TBE + influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TBE + influenza vaccine.